The report "Platelet Rich Plasma" Market by Sample type (Pure PRP, Leukocyte-rich PRP, Pure PRF), Origin (Autologous, Allogenic, and Homologous), Application (Orthopaedic surgery, Cosmetic surgery, General surgery, and neurosurgery) & Region (North America, Europe, Asia Pacific, and Rest of the world)- Global Forecast to 2030. "The Global Platelet Rich Plasma Market share was USD 314 million in 2020. The market is forecasted to reach USD 985 million by 2030, representing a CAGR of 12.12%% throughout the forecasted period.
To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/platelet-rich-plasma-market
KEY FACTORS THAT ARE CONTINUOUSLY AUGMENTING THE MARKET GROWTH
The worldwide market is expected to be driven by an increasing number of sports injuries and surgical and cosmetic procedures throughout the forecasted duration time.
By Sample Type, the Pure PRP held the highest share in 2020
The Platelet Rich Plasma (PRP) market is segmented into Pure PRP, Leukocyte-rich PRP, and Pure PRF based on Sample type. The Pure PRP segment is projected to grow at the highest rate. The segment's dominance can be primarily attributed to technical improvements in PRP devices, which have led to the rise in usage of pure PRP in various situations, as well as rich platelet content, which are expected to enhance the segment's growth in the coming years. Additionally, the worldwide industry has also benefited from technological improvements such as smart home diagnostic kits.
By Origin, the "Autologous" accounted for the maximum share of the market in 2020
The Platelet Rich Plasma (PRP) market is divided into Autologous, Allogenic, and Homologous based on Origin. Autologous held the largest market share in 2020. Autologous platelet-rich plasma (PRP) is a safe, straightforward, and cost-effective treatment that promotes cell proliferation, migration, and angiogenesis. In the treatment of chronic non-healing ulcers, autologous PRP is quite effective. The need for autologous PRP is likely to rise, particularly in developed nations throughout the world.
By Application, the "Orthopaedic surgery" accounted for the maximum share of the market in 2020
Based on the Application, the Platelet Rich Plasma market is divided into orthopaedic surgery, Cosmetic surgery, General surgery, and Neurosurgery. Orthopaedic surgery held the largest market share in 2020. During the projection period, the segment is expected to be driven by an increase in the number of orthopaedic procedures.
By Region, the "North America" accounted for the maximum share of the market in 2020
Based on Regions, North America is the fastest-growing market. The increase in the incidence of numerous ailments, such as arthritis, well-established healthcare infrastructure, improved regulatory environment, and government assistance, contribute to market expansion in the United States.
SOME OF THE NOTABLE PLAYERS ARE PREVAILING IN THE MARKET.
Some of the leading players in the Platelet Rich Plasma Market include SelfDiagnostics, Quidel Corporation, F. Hoffmann-La Roche Ltd., Dickinson and Company, Trinity Biotech plc, Becton, Bionime Corporation, Abbott, ARKRAY, Inc., ACON Laboratories, Inc., and Assure Tech. (Hangzhou) Co., Ltd.
Recent Developments: -